Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure

Kapur, Navin K.; Paruchuri, Vikram; Korabathina, Ravikiran; Al-Mohammdi, Ramzi; Mudd, James O.; Prutkin, Jordan M.; Esposito, Michele; Shah, Ameer T.; Kiernan, Michael S.; Sech, Candice; Pham, Duc Thinh; Konstam, Marvin A.; DeNofrio, David

doi:10.1016/j.healun.2011.07.005

Cited by 99 publications

(63 citation statements)

References 23 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…TandemHeart is not FDA-approved for use as an RVAD. 36 The Impella RP, a catheter-mounted axial flow pump is undergoing evaluation for management of RVF. 38 A potential advantage of the Impella RP device is the need for only a single venous access site.…”

Section: Right-sided Supportmentioning

confidence: 99%

2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d'intervention)∗

Rihal

Naidu

Givertz

et al. 2015

Journal of Cardiac Failure

Self Cite

244

319

View full text Add to dashboard Cite

Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella(®); left atrial to femoral artery bypass pumps, specifically the TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for right-sided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.

show abstract

Section: Right-sided Supportmentioning

confidence: 99%

2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d'intervention)∗

Rihal

Naidu

Givertz

et al. 2015

Journal of Cardiac Failure

Self Cite

244

319

View full text Add to dashboard Cite

show abstract

“…This device can provide a flow up to 5 L/mn and is FDA-approved for left ventricular support for up to 6 h. Mortality rate is similar, while limb ischemia and bleeding are more common when compared to the intra-aortic balloon pump in patients with cardiogenic shock after an acute myocardial infarction [53]. The TandemHeart has also been used for RV support [54,55]. …”

Section: Other Extracorporeal Circulatory Support Devicesmentioning

confidence: 99%

Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists

Hamdi

Palmer²

2017

Am J Nephrol

View full text Add to dashboard Cite

Acute kidney injury in the intensive care unit (ICU) is a manifestation of an underlying severe illness that commonly involves other organ systems. Pulmonary, cardiac, and hepatic failures are the most prevalent. This article provides a simplified review of the technical aspects of extracorporeal cardiopulmonary and liver support devices used in the adult ICU patient, as well as a summary of the most relevant and up-to-date clinical evidence that supports their use.

show abstract

“…Finally, patients with right ventricular (RV) failure are at considerably higher risk for morbidity and mortality when presenting with AMI, ADHF, or CS. Use of MCS for RV or biventricular support has been reported [35][36][37] and represents an important new use for this technology.…”

Section: Emerging Populationsmentioning

confidence: 99%

“…Close monitoring for antegrade cannula migration is essential and may present as hypoxic respiratory failure, hemothorax, hemoptysis, decreased cardiac output, and an acute decrease in device flow. TandemHeart is not FDA-approved for use as an RVAD [36]. The Impella RP, a catheter-mounted axial flow pump is undergoing evaluation for management of RVF [38].…”

Section: Right-sided Supportmentioning

confidence: 99%

2015 SCAI/ACC/HFSA/STS clinical expert consensus statement on the use of percutaneous mechanical circulatory support devices in cardiovascular care (Endorsed by the American heart assocation, the cardiological society of India, and sociedad latino Americana de cardiologia intervencion; Affirmation of value by the canadian association of interventional cardiology–association canadienne de cardiologie d'intervention)

Rihal

Naidu

Givertz

et al. 2015

Cathet Cardio Intervent

Self Cite

View full text Add to dashboard Cite

Although historically the intra-aortic balloon pump has been the only mechanical circulatory support device available to clinicians, a number of new devices have become commercially available and have entered clinical practice. These include axial flow pumps, such as Impella V R ; left atrial to femoral artery bypass pumps, specifically the is approached by other guideline developers and asked to review and consider guidelines for endorsement. Guidelines developed by external organizations will be considered for affirmation of value. The CAIC may not agree with every recommendation in such a document, but overall considers the document to be of educational value to its members. Catheterization and Cardiovascular Interventions 85:E175-E196 (2015)TandemHeart; and new devices for institution of extracorporeal membrane oxygenation. These devices differ significantly in their hemodynamic effects, insertion, monitoring, and clinical applicability. This document reviews the physiologic impact on the circulation of these devices and their use in specific clinical situations. These situations include patients undergoing high-risk percutaneous coronary intervention, those presenting with cardiogenic shock, and acute decompensated heart failure. Specialized uses for rightsided support and in pediatric populations are discussed and the clinical utility of mechanical circulatory support devices is reviewed, as are the American College of Cardiology/American Heart Association clinical practice guidelines.

show abstract

Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure

Cited by 99 publications

References 23 publications

Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists

Contact Info

Product

Resources

About